Allarity Therapeutics, Inc. Convertible Debt, Current
Allarity Therapeutics, Inc. (ALLR) had Convertible Debt, Current of $2.69 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2023-11-14
- 2023-03-31: Convertible Debt, Current $2.69M.
- 2022-12-31: Convertible Debt, Current $2.64M.
- 2020-12-31: Convertible Debt, Current $1.33M.
USD
| Period end | Convertible Debt, Current |
|---|---|
| 2023-03-31 | $2.69M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.64M 10-Q · filed 2023-11-14 |
| 2020-12-31 | $1.33M 10-Q/A · filed 2022-05-17 |
SEK
| Period end | Convertible Debt, Current |
|---|---|
| 2018-11-29 | 200.00M SEK 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |